Primary Site >> Liver Cancer
Gene >> FLT3
| 1. | |||||||||||
| Journal: | Cancer Res. 2006 Dec 15;66(24):11851-8. | ||||||||||
| Title: | Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. | ||||||||||
| Author: | Liu, Li|Cao, Yichen|Chen, Charles|Zhang, Xiaomei|McNabola, Angela|Wilkie, Dean|Wilhelm, Scott|Lynch, Mark|Carter, Christopher | ||||||||||
| PMID: | 17178882 | ||||||||||
| 2. | |||||||||||
| Journal: | Semin Oncol. 2006 Aug;33(4):392-406. | ||||||||||
| Title: | Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. | ||||||||||
| Author: | Gollob, Jared A|Wilhelm, Scott|Carter, Chris|Kelley, Susan L | ||||||||||
| PMID: | 16890795 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann Oncol. 2007 Jun;18 Suppl 6:vi22-5. | ||||||||||
| Title: | Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib. | ||||||||||
| Author: | Bracarda, S|Caserta, C|Sordini, L|Rossi, M|Hamzay, A|Crino, L | ||||||||||
| PMID: | 17591826 | ||||||||||
| 4. | |||||||||||
| Journal: | J Gastrointest Cancer. 2007;38(2-4):154-6. | ||||||||||
| Title: | Effective palliation of advanced cholangiocarcinoma with sorafenib: a two-patient case report. | ||||||||||
| Author: | LaRocca, Renato V|Hicks, Matthew D|Mull, Lennea|Foreman, Brenda | ||||||||||
| PMID: | 19089671 | ||||||||||
| 5. | |||||||||||
| Journal: | BioDrugs. 2009;23(6):377-89. | ||||||||||
| Title: | Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies. | ||||||||||
| Author: | Papaetis, Georgios S|Syrigos, Kostas N | ||||||||||
| PMID: | 19894779 | ||||||||||
| 6. | |||||||||||
| Journal: | Gerontology. 2010;56(3):303-9. | ||||||||||
| Title: | Antiangiogenic drugs in oncology: a focus on drug safety and the elderly - a mini-review. | ||||||||||
| Author: | Boehm, S|Rothermundt, C|Hess, D|Joerger, M | ||||||||||
| PMID: | 19940466 | ||||||||||
| 7. | |||||||||||
| Journal: | Hepatogastroenterology. 2010 May-Jun;57(99-100):426-9. | ||||||||||
| Title: | Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China. | ||||||||||
| Author: | Qun, Wang|Tao, Yin | ||||||||||
| PMID: | 20698202 | ||||||||||
| 8. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2011;12(2):497-505. | ||||||||||
| Title: | Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression. | ||||||||||
| Author: | Huang, Shouqing|Lin, Jianzh|Guo, Na|Zhang, Min|Yun, Xia|Liu, Song|Zhou, Ji|He, Ellen|Skog, Sven | ||||||||||
| PMID: | 21545220 | ||||||||||
| 9. | |||||||||||
| Journal: | Eur J Med Res. 2011 Nov 10;16(11):491-4. | ||||||||||
| Title: | Sunitinib induced pyoderma gangrenosum-like ulcerations. | ||||||||||
| Author: | Akanay-Diesel, S|Hoff, N P|Kurle, S|Haes, J|Erhardt, A|Haussinger, D|Schulte, K-W|Bolke, Edwin|Matuschek, C|Budach, W|Gerber, P A|Homey, B | ||||||||||
| PMID: | 22027642 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Sci. 2012 Jan;103(1):26-33. | ||||||||||
| Title: | Transforming growth factor-beta-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis. | ||||||||||
| Author: | Nakamura, Masaki|Kitaura, Jiro|Enomoto, Yutaka|Lu, Yang|Nishimura, Koutarou|Isobe, Masamichi|Ozaki, Katsutoshi|Komeno, Yukiko|Nakahara, Fumio|Oki, Toshihiko|Kume, Haruki|Homma, Yukio|Kitamura, Toshio | ||||||||||
| PMID: | 21943131 | ||||||||||
| 11. | |||||||||||
| Journal: | Afr J Tradit Complement Altern Med. 2012 Apr 2;9(3):431-9. eCollection 2012. | ||||||||||
| Title: | Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays. | ||||||||||
| Author: | Qiu, Yun-Qing|Zhou, Jue|Kang, Xin-Shan|Shen-Tu, Jian-Zhong|Ding, Lie-Ming|Tan, Fen-Lai|Guo, Jing|Li, Lan-Juan | ||||||||||
| PMID: | 23983378 | ||||||||||
| 12. | |||||||||||
| Journal: | Anticancer Agents Med Chem. 2012 Nov;12(9):1088-97. | ||||||||||
| Title: | Rational drug design for identifying novel multi-target inhibitors for hepatocellular carcinoma. | ||||||||||
| Author: | Temirak, Ahmed|Abdulla, Mona|Elhefnawi, Mahmoud | ||||||||||
| PMID: | 22583422 | ||||||||||
| 13. | |||||||||||
| Journal: | Curr Med Chem. 2012;19(7):938-44. | ||||||||||
| Title: | Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development. | ||||||||||
| Author: | Ranieri, G|Gadaleta-Caldarola, G|Goffredo, V|Patruno, R|Mangia, A|Rizzo, A|Sciorsci, R L|Gadaleta, C D | ||||||||||
| PMID: | 22214462 | ||||||||||
| 14. | |||||||||||
| Journal: | Mediterr J Hematol Infect Dis. 2014 Feb 17;6(1):e2014016. | ||||||||||
| Title: | Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature. | ||||||||||
| Author: | Senapati, Jayastu|Devasia, Anup J|Ganapule, Abhijeet|George, Leni|Viswabandya, Auro | ||||||||||
| PMID: | 24678393 | ||||||||||
| 15. | |||||||||||
| Journal: | Onco Targets Ther. 2015 Dec 8;8:3691-701. | ||||||||||
| Title: | Profile of nintedanib in the treatment of solid tumors: the evidence to date. | ||||||||||
| Author: | Awasthi, Niranjan|Schwarz, Roderich E | ||||||||||
| PMID: | 26677336 | ||||||||||
| 16. | |||||||||||
| Journal: | J Pediatr Hematol Oncol. 2016 Apr;38(3):240-2. | ||||||||||
| Title: | Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia. | ||||||||||
| Author: | Tavil, Betul|Isgandarova, Fatma|Bayhan, Turan|Unal, Sule|Kuskonmaz, Baris|Gumruk, Fatma|Cetin, Mualla | ||||||||||
| PMID: | 26907662 | ||||||||||
| 17. | |||||||||||
| Journal: | Turk J Med Sci. 2016 Feb 17;46(2):572-81. | ||||||||||
| Title: | Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma. | ||||||||||
| Author: | Aydin, Muammer Merve|Bayin, Nermin Sumru|Acun, Tolga|Yakicier, Mustafa Cengiz|Akcali, Kamil Can | ||||||||||
| PMID: | 27511526 | ||||||||||
| 18. | |||||||||||
| Journal: | Future Oncol. 2017 Jul 13. | ||||||||||
| Title: | Cabozantinib in the treatment of hepatocellular carcinoma. | ||||||||||
| Author: | B Peters, Mary Linton|Miksad, Rebecca A | ||||||||||
| PMID: | 28703624 | ||||||||||
| 19. | |||||||||||
| Journal: | J Exp Pharmacol. 2018 May 9;10:9-17. | ||||||||||
| Title: | Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. | ||||||||||
| Author: | Al-Fayoumi, Suliman|Hashiguchi, Taishi|Shirakata, Yuka|Mascarenhas, John|Singer, Jack W | ||||||||||
| PMID: | 29785143 | ||||||||||